Entero Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Boca Raton, Florida, focused on advancing innovative, orally administered therapies to address unmet needs in gastrointestinal diseases. Leveraging its proprietary technology platform, Entero aims to develop targeted treatments that improve patient outcomes and enhance quality of life. With a commitment to scientific excellence and patient-centered solutions, the company is poised to make significant contributions to the field of gastrointestinal health.